Skip to content

Clinical trials

Phase 3 Leukemia, Myeloid, Acute trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 3 Country / region: Poland Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20081
20103
20111
20132
20142
20152
20163
20177
20183
20191
20213
20222
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting5
Terminated5
Recruiting4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.3
Daiichi Sankyo3
AbbVie2
Astex Pharmaceuticals, Inc.2
Celgene2
Pfizer2
Boehringer Ingelheim1
Clavis Pharma1
Cornerstone Pharmaceuticals1
Cyclacel Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute36
Leukemia7
Myelodysplastic Syndromes3
Leukemia, Myelomonocytic, Chronic2
Neoplasms2
Pathologic Complete Response2
Congenital Abnormalities1
Hematologic Diseases1
Hematologic Neoplasms1
Leukemia, Basophilic, Acute1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.